Magnesium Sulfate Reduced Opioid Consumption in Obese Patients Undergoing Sleeve Gastrectomy: a Prospective, Randomized Clinical Trial

Obes Surg. 2018 Sep;28(9):2783-2788. doi: 10.1007/s11695-018-3243-7.

Abstract

Objective: The purpose of the study was to investigate the effect of magnesium sulfate on pain management for pain after sleeve gastrectomy operation.

Design: A prospective, randomized, placebo-controlled clinical study.

Setting: University hospital.

Participants: Eighty patients undergoing sleeve gastrectomy.

Measurements and main results: Visual analog scale for the evaluation of pain, sedation score, mean arterial pressure, heart rate, and total analgesic consumption was recorded. Serum magnesium levels were determined before the operation, at the end of the operation, and at 24 h. There were no significant differences between the groups with respect to demographics, and sedation scores. Cumulative morphine consumption and pain scores were found to be higher in the control group than the magnesium group.

Conclusion: Perioperative use of magnesium sulfate reduced postoperative pain and opioid consumption in obese patients undergoing sleeve gastrectomy operations.

Keywords: Bariatric surgery; Magnesium sulfate; Postoperative pain; Sleeve gastrectomy.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Analgesics, Opioid / therapeutic use*
  • Bariatric Surgery* / adverse effects
  • Bariatric Surgery* / statistics & numerical data
  • Gastrectomy* / adverse effects
  • Gastrectomy* / statistics & numerical data
  • Humans
  • Magnesium Sulfate / therapeutic use*
  • Pain, Postoperative* / drug therapy
  • Pain, Postoperative* / epidemiology
  • Prospective Studies

Substances

  • Analgesics, Opioid
  • Magnesium Sulfate